120 related articles for article (PubMed ID: 88539)
1. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.
Irie RF; Giuliano AE; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539
[TBL] [Abstract][Full Text] [Related]
2. A membrane antigen common to human cancer and fetal brain tissues.
Irie RF; Irie K; Morton DL
Cancer Res; 1976 Sep; 36(9 PT 2):3510-7. PubMed ID: 61813
[TBL] [Abstract][Full Text] [Related]
3. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
4. A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patients.
Higuchi M; Robinson DS; Cailleau R; Irie RF; Morton DL
Clin Exp Immunol; 1980 Jan; 39(1):90-6. PubMed ID: 7389200
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
6. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
9. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
Takahashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
[TBL] [Abstract][Full Text] [Related]
10. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of antibody against oncofetal antigen-I in patients with gynecologic tumors].
Higuchi M; Ohsawa S
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):25-30. PubMed ID: 2324586
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of OFA-I in the immunological rejection mechanism in trophoblasts].
Takeuchi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1893-8. PubMed ID: 3902999
[TBL] [Abstract][Full Text] [Related]
13. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells.
Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB
Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181
[TBL] [Abstract][Full Text] [Related]
14. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
Gupta RK; Morton DL
J Natl Cancer Inst; 1983 Jun; 70(6):993-1004. PubMed ID: 6190035
[TBL] [Abstract][Full Text] [Related]
17. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
Takeyama H; Watanabe T; Livingston PO
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
19. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
20. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
